Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Martin Spycher"'
Autor:
Claudia Duehrkop, Yara Banz, Rolf Spirig, Sylvia Miescher, Marc W Nolte, Martin Spycher, Richard A G Smith, Steven H Sacks, Robert Rieben
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e72059 (2013)
BACKGROUND:Ischemia/reperfusion injury of lower extremities and associated lung damage may result from thrombotic occlusion, embolism, trauma, or surgical intervention with prolonged ischemia and subsequent restoration of blood flow. This clinical en
Externí odkaz:
https://doaj.org/article/cc69c3666e684bdaa8a06500b0f6f4f5
Autor:
Adrian W. Zuercher, Mel Berger, Reinhard Bolli, Cédric Vonarburg, Martin Spycher, Amgad Shebl, Rolf Spirig, Christoph Kempf, Fabian Käsermann, Sylvia Miescher
Publikováno v:
Nijkamp and Parnham's Principles of Immunopharmacology ISBN: 9783030108090
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50de53990989806754a1f05f7c779b12
https://doi.org/10.1007/978-3-030-10811-3_20
https://doi.org/10.1007/978-3-030-10811-3_20
Autor:
Liane, Hoefferer, Isabelle, Glauser, Annette, Gaida, Katharina, Willimann, Adriano, Marques Antunes, Brigitte, Siani, Sandra, Wymann, Eleonora, Widmer, Ibrahim, El Menyawi, Reinhard, Bolli, Martin, Spycher, Martin, Imboden
Publikováno v:
Transfusion. 55
The passive transfer of antibodies specific to blood groups A and B (also called isoagglutinins) contained in immunoglobulin (Ig)G products for intravenous administration (IVIG) is believed to be largely responsible for rare but sometimes serious IVI
Autor:
Rachael Easton, Svetlana Diditchenko, Martin Spycher, Monika Edler, Reinhard Bolli, Olivia Bossart, Dominik Stadler, Ingo Pragst, Jill Haynes, Samuel D. Wright, CSL Behring AG
Publikováno v:
Journal of the American College of Cardiology. (13):E492
Autor:
Rachael Easton, Svetlana Diditchenko, Martin Spycher, Marcel Waelchli, Martin Imboden, Sabrina Schenk, Ingo Pragst, Samuel D. Wright, CSL Behring AG
Publikováno v:
Journal of the American College of Cardiology. (13):E491
The efflux of cellular cholesterol mediated by apoA-I and ATP-binding cassette transporter A1 (ABCA1) is thought to underlie many of the cardiovascular benefits of HDL. Several groups have manufactured apoA-I preparations with the aim of making an in